Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
|ClinicalTrials.gov Identifier: NCT00015769|
Recruitment Status : Completed
First Posted : May 7, 2001
Last Update Posted : March 4, 2008
National Institute of Mental Health (NIMH)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||No date given|
|Study Completion Date :||April 2003|
Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord. 1999 Sep;1(1):61-5.
Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 1997 Nov;58(11):470-8.